Domain Associates

Domain Associates

Signal active

Investment Firm

Overview

Founded in 1985, Domain Associates, L.L.C. is a venture capital firm with an exclusive focus on life sciences. With $2 billion of capital under management, Domain is headquartered in Princeton, NJ with a second office in San Diego, CA.

Domain’s three major investment segments are pharmaceuticals, specialty pharmaceuticals, and medical devices, while additional areas of interest include biomaterials, bioinstrumentation, and diagnostics. The Partners of Domain have a total of close to 200 person-years of experience among them in the healthcare/venture capital industries and have been involved in the formation and growth of more than 200 life-sciences companies. The highly focused network, experience, and reputation of this team have made it one of the top private-equity groups participating in the healthcare field.

Highlights

Founded

1985

Industry

Venture Capital

Employees

11-50

Investment

306

Lead Investment

63

Exits

93

Stages

Early Stage Venture, Late Stage Venture, Seed

Investor Type

Venture Capital

Location

United States, North America

Contact Information

Social

Profile Resume

Domain Associates, established in 1985 and headquartered in United States, North America., specializes in Early Stage Venture, Late Stage Venture, Seed investments across Information Technology, Biotechnology, Computer, Consumer, Health Care, Pharmaceutical, Medical Device, Life Science, Financial Services, Finance. The organization boasts a portfolio of 306 investments, with an average round size of $28.7M and 93 successful exits. Their recent investments include Neuron Systems, Johnson & Johnson Development Corporation, ProteinSimple, Mitsui Global Investment, Wellcome Trust. The highest investment round they participated in was $601.4B. Among their most notable exits are Neuron Systems and Johnson & Johnson Development Corporation. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.

Employees

imagePlace Kim P. Kamdar

Kim P. Kamdar

Partner

imagePlace Dennis Podlesak

Dennis Podlesak

Venture Capitalist

imagePlace Jim Blair

Jim Blair

Partner

imagePlace Jesse I. Treu

Jesse I. Treu

Founding Partner

imagePlace Brian Halak

Brian Halak

Partner

imagePlace Nicole Vitullo

Nicole Vitullo

Partner

Investment portfolio

Domain Associates has made 306 investments. Their most recent investment was on Nov 03, 2021, when Antios Therapeutics raised $75.0M.

Domain Associates has made 39 diversity investments. Their most recent diversity investment was on Oct 13, 2021, when Axial Biotherapeutics raised $37.3M.

investments

306

Diversity investments

39

Lead investments

63

Number of exits

93

Investments

306

Annouced DateOrganization NameIndustryMoney Raised
Oct 13, 2021
Axial Biotherapeutics Axial Biotherapeutics
Biotechnology37.3M
Nov 03, 2021
Antios Therapeutics Antios Therapeutics
Biotechnology75.0M
Aug 15, 2022
Fractyl Health Fractyl Health
Biotechnologynull
Apr 14, 2023--24.0M

Exits

93

Funding Timeline

Funding rounds

306

Investors

0

Funds

4

Funding Rounds

306

Domain Associates has raised 306 rounds. Their latest funding was raised on Apr 14, 2023 from a Series G - Epic Sciences round.

Annouced DateTransaction NameNumber of InvestorsMoney RaisedLead Investor
Oct 13, 2021
Series C - Axial Biotherapeutics Series C - Axial Biotherapeutics
-37.3M-
Nov 03, 2021
Series B - Antios Therapeutics Series B - Antios Therapeutics
-75.0M-
Aug 15, 2022
Series F - Fractyl Health Series F - Fractyl Health
-0-
Apr 14, 2023
Series G - Epic Sciences Series G - Epic Sciences
-24.0M-

Investors

0

There is no funding round available on this profile

Fund raised

2

Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.

Annouced DateFund NameMoney Raised
May 10, 2013
fund image OTPPLESS
1.0M
May 11, 2013
fund image OTPPLESS
1.0M

Invest in industries

Recent Activity

There is no recent news or activity for this profile.